The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions
出版年份 2015 全文链接
标题
The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions
作者
关键词
CXCR1/2, Type 1 diabetes, Neutrophils, Pancreatic islets, Chemokine, Chemokine receptor
出版物
Current Diabetes Reports
Volume 15, Issue 10, Pages -
出版商
Springer Nature
发表日期
2015-08-14
DOI
10.1007/s11892-015-0638-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CXCL1/CXCL8 (GROα/IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitro
- (2014) Tatsushi Omatsu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- CXCR2 Receptor Antagonists: A Medicinal Chemistry Perspective
- (2014) Michael Dwyer et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
- (2014) Antonio Citro et al. DIABETES
- Macrophages and -cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes
- (2014) J. Diana et al. EMBO Molecular Medicine
- Leukocyte Migration into Inflamed Tissues
- (2014) Sussan Nourshargh et al. IMMUNITY
- Combining MK626, a Novel DPP-4 Inhibitor, and Low-Dose Monoclonal CD3 Antibody for Stable Remission of New-Onset Diabetes in Mice
- (2014) Lei Ding et al. PLoS One
- Compartmentalized Protective and Detrimental Effects of Endogenous Macrophage Migration-Inhibitory Factor Mediated by CXCR2 in a Mouse Model of Myocardial Ischemia/Reperfusion
- (2013) Elisa A. Liehn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Anti-Inflammatory Strategies to Enhance Islet Engraftment and Survival
- (2013) Antonio Citro et al. Current Diabetes Reports
- Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
- (2013) A. Valle et al. DIABETES
- Reduced Blood Leukocyte and Neutrophil Numbers in the Pathogenesis of Type 1 Diabetes
- (2013) M. Harsunen et al. HORMONE AND METABOLIC RESEARCH
- Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation
- (2012) D. A. Schneider et al. DIABETES OBESITY & METABOLISM
- Immunological pathways to β-cell damage in Type 1 diabetes
- (2012) M. Peakman DIABETIC MEDICINE
- Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking
- (2012) Maria-Jesus Sanz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development
- (2012) Katie O'Callaghan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
- (2012) Thomas Jamieson et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR1/2 inhibition enhances pancreatic islet survival after transplantation
- (2012) Antonio Citro et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
- (2012) Richard B. Moss et al. Journal of Cystic Fibrosis
- The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
- (2012) Yan Ning et al. MOLECULAR CANCER THERAPEUTICS
- Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes
- (2012) Julien Diana et al. NATURE MEDICINE
- Analysis of Beta-Cell Gene Expression Reveals Inflammatory Signaling and Evidence of Dedifferentiation following Human Islet Isolation and Culture
- (2012) Sarita Negi et al. PLoS One
- G protein-coupled receptor modulation with pepducins: moving closer to the clinic
- (2011) Patricia Dimond et al. Annals of the New York Academy of Sciences
- Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor
- (2011) R. Virtala et al. CLINICAL AND EXPERIMENTAL ALLERGY
- C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277
- (2011) Raffaella Buzzetti et al. DIABETES
- Serum CXCL1 concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity of anti-islet autoimmune activity
- (2011) Kazuma Takahashi et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation
- (2011) Seema Singh et al. MICROVASCULAR RESEARCH
- Ischemia and reperfusion—from mechanism to translation
- (2011) Holger K Eltzschig et al. NATURE MEDICINE
- Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes
- (2011) Kathryn M. Sumpter et al. PEDIATRIC DIABETES
- A common intracellular allosteric binding site for antagonists of the CXCR2 receptor
- (2010) K Salchow et al. BRITISH JOURNAL OF PHARMACOLOGY
- Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
- (2010) Michelle L. Varney et al. CANCER LETTERS
- Role of CCL2/MCP-1 in Islet Transplantation
- (2010) Raffaella Melzi et al. CELL TRANSPLANTATION
- The Chemokine Receptor CXCR2 Ligand KC (CXCL1) Mediates Neutrophil Recruitment and Is Critical for Development of Experimental Lyme Arthritis and Carditis
- (2010) A. M. Ritzman et al. INFECTION AND IMMUNITY
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
- (2010) Yenkel Grinberg-Bleyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
- (2009) O. Holz et al. EUROPEAN RESPIRATORY JOURNAL
- CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
- (2009) Yoichi Matsuo et al. INTERNATIONAL JOURNAL OF CANCER
- Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area
- (2009) Song Xue et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
- (2008) Allisson Freire Bento et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity
- (2008) Monika Pruenster et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation